Tobira files for IPO; withdrawn, then revived two months later; once again withdrawn
Tobira Therapeutics Inc. (developing cenicriviroc for multiple diseases) filed for its initial public offering.
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.